To bridge the gap until generic versions become available, Gilead has also committed to supply the product at no profit to the chosen companies until the selected generic manufacturers are able to ...

Antiretroviral drugs, for instance, which suppress the virus and prevent it from replicating, are successfully used to treat HIV infection. "Many HIV-positive women who have become pregnant have ...

The companies have presented positive Phase II data during an oral session at IDWeek 2024, in Los Angeles, US.

The details you provide on this page will not be used to send unsolicited email ... approval of the drug and WHO pre-qualification. The drug has been approved in Europe and the US as a treatment for ...

Namibia has made significant strides in stemming the spread of HIV and AIDS through education and prevention. However, for ...

The government has received a $600 million (about Shs2.205 trillion) grant from the Global Fund to treat HIV/Aids, ...

Alchemy, which sets up pharmacies in community clinics, said that it had raised $31 million from Andreessen Horowitz and ...

Progress has been made in HIV care. However, that doesn’t mean you don’t need a detailed plan for taking care of an ...

Gilead Sciences, Inc. (Nasdaq: GILD) and Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today ...

Moderate and high SUD risk was significantly increased among people living with HIV during the COVID-19 pandemic, between 2018 and 2022.

MONTREAL - Theratechnologies (NASDAQ:THTX) Inc. (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company, has revealed details from a study focusing on the treatment outcomes for heavily treatment ...